Drug Type Small molecule drug |
Synonyms JNJ 54717793, JNJ54717793 |
Target |
Action antagonists |
Mechanism OX1R antagonists(Orexin receptor type 1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H18F4N6O |
InChIKeyNWUAUSABGZEYEW-WQVCFCJDSA-N |
CAS Registry1628843-99-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Preclinical | United States | 08 Oct 2020 |